Document Detail

Aliskiren in the treatment of hypertension and organ damage.
MedLine Citation:
PMID:  21106033     Owner:  NLM     Status:  In-Data-Review    
Hypertension is one of the most important risk factor and cause of cardiovascular diseases (CVD). Chronic activation of the renin-angiotensin-aldosterone system (RAAS) plays a key role in the development of hypertension, cardiac and renal diseases. RAAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs), improve cardiovascular and renal outcomes. However, studies have shown that residual morbidity and mortality remains high, despite current optimal treatment. More comprehensive control of the RAAS might provide additional reductions in morbidity and mortality. Direct renin inhibitors such aliskiren offer the potential for enhanced RAAS control as they target the system at the point of activation, thereby reducing plasma renin activity; by contrast, ACEI and ARBs increase plasma renin activity. The efficacy of aliskiren in the reduction of major clinical events is being tested in large ongoing clinical trials. This review examines the efficacy, safety, and tolerability of aliskiren, and considers the evidence for the potential organ protection benefits of this treatment.
Graziano Riccioni
Related Documents :
2569653 - Blood pressure reduction in hypertensive-diabetic rats by the somatostatin analog mk-678.
1090153 - Clinical effects of bilateral nephrectomy.
738483 - Metropolitan deconcentration: subareal in-migration and central city to ring mobility p...
Publication Detail:
Type:  Journal Article     Date:  2010-11-25
Journal Detail:
Title:  Cardiovascular therapeutics     Volume:  29     ISSN:  1755-5922     ISO Abbreviation:  Cardiovasc Ther     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101319630     Medline TA:  Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  77-87     Citation Subset:  IM    
Copyright Information:
© 2010 Blackwell Publishing Ltd.
Cardiology Unit, San Camillo de Lellis Hospital, Manfredonia, Foggia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Targeting small airways in asthma: improvement in clinical benefit?
Next Document:  Differences in Angiotensin Convertase Enzyme (ACE) Activity and Expression May Contribute to Shorter...